Cytotoxic chemotherapy suppresses the hematopoietic system, and the most serious hematologic toxicity is neutropenia. This can decrease a risk of infection that causes delays in treatment and reduction of dose intensity, which reduces therapeutic outcome. Filgrastim is used to increase neutrophils level whose therapeutic effect is unknown. The effectiveness of filgrastim is based on the ANC level pre- and post-therapy. This study aimed to analyze the use of filgrastim on ANC level changes in acute leukemia children with neutropenia, and to analyze the patient that achieve ANC level’s targeted therapy = 1000 cell/mm3. A prospective observational study with a longitudinal design was conducted from June to October 2016. The inclusion criteria of the study were patients who diagnosed acute leukemia with neutropenia and received filgrastim 10 µg/kgBW for 3, 4, 5 days. Patients’ ANC levels were measured before and after filgrastim therapy. This study has been approved its ethical clearance by Dr. Saiful Anwar Hospital, Malang. Data were obtained on the basis of neutropenic episodes, followed by 7 episodes of obtaining filgrastim for 3 days, 1 episode of obtaining filgrastim for 4 days, and 7 episodes of obtaining filgrastim for 5 days. Thus, it consists of 15 episodes. In 3 days, ANC levels increased by 9.5 fold from 381.3 ± 91.8 cell/mm3 to 3984.9 ± 426.8 cell/mm3, but in 5 days, ANC levels decreased by 0.9 fold from 200.9 cell/mm3 ± 98.2 to 189.7 ± 14.2 cell/mm3. Filgrastim was able to increased the ANC levels around nine fold for 3 days of theraphy. There were 53% neutropenia patients who achieved the goal of therapy. Filgrastim therapy with dose 10 µg/kgBW for 3 to 5 days has been able to reach the therapeutic target of 53% in acute leukemia children with neutropenia. The increased levels of ANC maximum was reached on the third day with increased levels of 9.5 fold.

Published by Universitas Airlangga
Journal Name Folia Medica Indonesiana
Contact Phone-
Contact Name -
Contact Email -
Location Kota surabaya, Jawa timur INDONESIA
Website FMI| https://e-journal.unair.ac.id/index.php/FMI|
ISSN ISSN : 23558393, EISSN : 2599056X, DOI : -,
Core Subject Education,
Meta Subject Other,
Meta DescFolia Medica Indonesiana publishes articles in the field of medical science in particular and health sciences in general, as well as a variety of other fields related to those two disciplines. Most of the articles are research article, and others are articles on case reports and literature review. In their presentation in the journal, the articles have passed meticulous editing process by the editors and review process and by competent peer reviewers, with national and international reputation, making the articles presented in this journal qualified, updated, and informative.
PenulisWidya, Reta Anggraeni , Nugroho, Susanto Winarsih, Sri , Yulistiani, Yulistiani
Publisher ArticleFaculty of Medicine, Universitas Airlangga
Subtitle Article Folia Medica Indonesiana Vol 55, No 1 (2019): March
Scholar Googlehttp://scholar.google.com/scholar?q=%2Bintitle%3A&…
View Articlehttps://e-journal.unair.ac.id/…
DOIhttps://doi.org/10.20473/fmi.v55i1.…
DOI Number DOI: 10.20473/fmi.v55i1.12543
Download Article [1] https://e-journal.unair.ac.id/FMI/articl…
Download Article [2] http://download.garuda.ristekdikti.go.id…

 

Statistical Analysis System Socialism: An Economic and Sociological Analysis Daily News and Analysis Foreign Policy Analysis Failure mode and effects analysis Security: A New Framework for Analysis Attributed goal-oriented requirements analysis Crowley Broadcast Analysis Goal-based Requirement Analysis Method (GBRAM) Analisis termal diferensial Analisis perilaku terapan Scenario Based Requirement Analysis Method Nanoparticle tracking analysis Analisis bahaya dan pengendalian titik kritis Analisis jalur Cornell Paper Perencanaan kelangsungan bisnis Value engineering Analisis jalur kritis